Chimeric Antigen Receptor (CAR) T Cell Therapy for Cancer. Challenges and Opportunities: An Overview
Author:
Publisher
Springer US
Link
http://link.springer.com/content/pdf/10.1007/978-1-0716-0759-6_14
Reference120 articles.
1. Wu S, Zhu W, Thompson P, Hannun YA (2018) Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun 9(1):3490. https://doi.org/10.1038/s41467-018-05467-z
2. Abbas Z, Rehman S (2018) An overview of cancer treatment modalities. IntechOpen, London. https://doi.org/10.5772/intechopen.76558
3. Arruebo M, Vilaboa N, Saez-Gutierrez B, Lambea J, Tres A, Valladares M, Gonzalez-Fernandez A (2011) Assessment of the evolution of cancer treatment therapies. Cancer 3(3):3279–3330. https://doi.org/10.3390/cancers3033279
4. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23(10):2346–2357. https://doi.org/10.1200/jco.2005.00.240
5. Rosenberg SA (2011) Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know. Nat Rev Clin Oncol 8(10):577–585. https://doi.org/10.1038/nrclinonc.2011.116
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12
2. Powering prescription: Mitochondria as “Living Drugs” – Definition, clinical applications, and industry advancements;Pharmacological Research;2024-01
3. The Promise of Immunotherapeutics and Vaccines in the Treatment of Cancer;Handbook of Oncobiology: From Basic to Clinical Sciences;2024
4. Flow cytometry: A powerful analytical technique for characterizing the biological function of biotherapeutics and biosimilars.;Journal of Pharmaceutical and Biomedical Analysis;2023-10
5. CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy;Cancer Cell International;2023-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3